Healthcare & Medical Devices Global On demand · 24-48h

Global Single Use Endoscopy Device Market Strategic Research Report

Global Single Use Endoscopy Device Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Single Use Endoscopy Device Market
$2.1B2025
13.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single Use Bronchoscopes (Value & Volume), Single Use Duodenoscopes (Value & Volume), Single Use Ureteroscopes (Value & Volume), Single Use Colonoscopes & Sigmoidoscopes (Value & Volume), Single Use Cystoscopes & Urological Endoscopes (Value & Volume), Single Use Nasopharyngoscopes & ENT Endoscopes (Value & Volume)

By Application: Pulmonology & Critical Care Bronchoscopy (Value & Volume), Gastrointestinal Endoscopy & ERCP (Value & Volume), Urology — Stone Management & Upper Tract Surveillance (Value & Volume), Colorectal Screening & Diagnostic Colonoscopy (Value & Volume), ENT & Nasopharyngeal Diagnostics (Value & Volume)

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Ambu A/S, Boston Scientific, Olympus Corporation, Karl Storz, Medtronic, Cook Medical, Verathon Inc., Pusen Medical, OTU Medical, Vathin Medical Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Market size 2025
$2.1B
Billion USD
Forecast CAGR
13.6%
2025-2032
Forecast 2032
$5.1B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

The global single use endoscopy device market has emerged as one of the most consequential sub-sectors within medical devices, with the market valued at approximately USD 2.1 billion in 2024 and on a trajectory to reach USD 5.8 billion by 2032. This growth reflects a structural shift in endoscopic practice across hospitals, ambulatory surgical centers, and outpatient clinics worldwide, driven by mounting clinical and regulatory pressure to eliminate cross-contamination risks associated with reusable flexible endoscopes. The market encompasses a broad spectrum of devices including single use bronchoscopes, duodenoscopes, ureteroscopes, colonoscopes, cystoscopes, and associated accessories, all designed for one-time procedural deployment and immediate disposal. The strategic importance of this market extends well beyond infection control, touching on hospital economics, supply chain resilience, and the broader transition toward value-based care models that reward procedural efficiency and patient safety outcomes.

Three converging forces are accelerating market expansion with measurable clinical and commercial consequences. First, a series of high-profile superbug outbreaks linked to inadequately reprocessed duodenoscopes—most notably carbapenem-resistant Enterobacteriaceae infections in U.S. academic medical centers—prompted the FDA to issue binding reprocessing guidance and ultimately endorse single use duodenoscopes as a safety-equivalent alternative, catalyzing institutional adoption at scale. Second, the rapid proliferation of ambulatory surgical centers in North America and Asia Pacific has created a structurally favorable customer base: facilities with high procedural throughput but without the infrastructure or staffing to manage complex reprocessing workflows, making disposable devices economically and operationally attractive. Third, continuous miniaturization of chip-on-tip camera technology and advances in single use polymer engineering have narrowed the image quality gap between disposable and reusable systems, removing a historically decisive clinical objection. The primary restraint on market expansion remains the higher per-procedure cost of single use devices relative to amortized reusable equivalents, a concern that is material in cost-sensitive health systems across emerging markets and among budget-constrained public hospitals in Europe.

This report delivers a comprehensive, data-anchored analysis of the global single use endoscopy device market across the 2025–2032 forecast period, with historical review extending to 2019. Coverage spans device type segmentation, application segmentation, five regional markets, and six priority country-level forecasts. The report profiles ten leading commercial participants with revenue context, competitive positioning analysis, and an assessment of recent merger, acquisition, and partnership activity. The findings are intended primarily for corporate strategy teams evaluating portfolio positioning, investment analysts modeling growth trajectories, M&A advisors assessing target quality, and procurement managers benchmarking supplier landscapes.

Market snapshot

Global Single Use Endoscopy Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 13.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.1B
2025
Forecast
$5.1B
2032
Volume
38
Million Units, 2025
Volume 2032
92.8
Million Units
Key companies
Ambu A/SBoston ScientificOlympus CorporationKarl StorzMedtronicCook MedicalVerathon Inc.Pusen Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single Use Bronchoscopes (Value & Volume)Single Use Duodenoscopes (Value & Volume)Single Use Ureteroscopes (Value & Volume)Single Use Colonoscopes & Sigmoidoscopes (Value & Volume)Single Use Cystoscopes & Urological Endoscopes (Value & Volume)Single Use Nasopharyngoscopes & ENT Endoscopes (Value & Volume)
By Application
Pulmonology & Critical Care Bronchoscopy (Value & Volume)Gastrointestinal Endoscopy & ERCP (Value & Volume)Urology — Stone Management & Upper Tract Surveillance (Value & Volume)Colorectal Screening & Diagnostic Colonoscopy (Value & Volume)ENT & Nasopharyngeal Diagnostics (Value & Volume)

Table of contents

Click a chapter to expand
01Executive Summary
  • 1.1 Market Synopsis
  • 1.2 Key Findings
  • 1.3 Strategic Recommendations
02Industry Overview & Forecast
  • 2.1 Market Definition & Scope
  • 2.2 Market Value & Volume Forecast (Million Units), 2025-2032
  • 2.3 CAGR Analysis & Confidence Intervals
  • 2.4 Historical Market Review, 2019-2024
  • 2.5 Scenario Analysis (Base, Bull, Bear Cases)
03Market Segmentation by Device Type
  • 3.1 Market by Device Type Overview
  • 3.2 Single Use Bronchoscopes (Value & Volume)
  • 3.3 Single Use Duodenoscopes (Value & Volume)
  • 3.4 Single Use Ureteroscopes (Value & Volume)
  • 3.5 Single Use Colonoscopes & Sigmoidoscopes (Value & Volume)
  • 3.6 Single Use Cystoscopes & Urological Endoscopes (Value & Volume)
  • 3.7 Single Use Nasopharyngoscopes & ENT Endoscopes (Value & Volume)
04Market Segmentation by Application
  • 4.1 Market by Application Overview
  • 4.2 Pulmonology & Critical Care Bronchoscopy (Value & Volume)
  • 4.3 Gastrointestinal Endoscopy & ERCP (Value & Volume)
  • 4.4 Urology — Stone Management & Upper Tract Surveillance (Value & Volume)
  • 4.5 Colorectal Screening & Diagnostic Colonoscopy (Value & Volume)
  • 4.6 ENT & Nasopharyngeal Diagnostics (Value & Volume)
05Regional Market Forecast
  • 5.1 Regional Revenue Share & CAGR (2024 vs 2032)
  • 5.2 North America (Value & Volume)
  • 5.3 Europe (Value & Volume)
  • 5.4 Asia Pacific (Value & Volume)
  • 5.5 Middle East & Africa
  • 5.6 Latin America
06Country-Level Market Forecast
  • 6.1 Top Countries Overview
  • 6.2 United States
  • 6.3 Germany
  • 6.4 United Kingdom
  • 6.5 China
  • 6.6 Japan
  • 6.7 India
07Growth Drivers & Inhibitors
  • 7.1 FDA Reprocessing Mandates & Duodenoscope Safety Rulings Accelerating Disposable Adoption
  • 7.2 Ambulatory Surgical Center Expansion Creating High-Volume Disposable-Preferred Customer Base
  • 7.3 Chip-on-Tip Camera Miniaturization Closing Image Quality Gap with Reusable Systems
  • 7.4 Market Restraints & Challenges
  • 7.5 Opportunities & White-Space Analysis
08Key Company Profiles
  • 8.1 Ambu A/S — Revenue, Strategy, Key Products
  • 8.2 Boston Scientific Corporation — Revenue, Strategy, Key Products
  • 8.3 Olympus Corporation — Revenue, Strategy, Key Products
  • 8.4 Karl Storz SE & Co. KG — Revenue, Strategy, Key Products
  • 8.5 Medtronic plc — Revenue, Strategy, Key Products
  • 8.6 Cook Medical — Revenue, Strategy, Key Products
  • 8.7 Verathon Inc. (Roper Technologies) — Revenue, Strategy, Key Products
  • 8.8 Pusen Medical — Revenue, Strategy, Key Products
  • 8.9 OTU Medical — Revenue, Strategy, Key Products
  • 8.10 Vathin Medical Technology — Revenue, Strategy, Key Products
09Competitive Landscape
  • 9.1 Market Concentration & Competitive Intensity
  • 9.2 Market Share Analysis (2024)
  • 9.3 Competitive Positioning Matrix
  • 9.4 Recent Developments: M&A, Partnerships & Product Launches (2023-2025)
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitute Products
  • 10.5 Competitive Rivalry Intensity
11PESTLE Analysis
  • 11.1 Political Factors
  • 11.2 Economic Factors
  • 11.3 Social & Demographic Factors
  • 11.4 Technological Factors
  • 11.5 Legal & Regulatory Factors
  • 11.6 Environmental Factors
12SWOT Analysis
  • 12.1 Market-Level Strengths
  • 12.2 Market-Level Weaknesses
  • 12.3 Strategic Opportunities
  • 12.4 External Threats
13Future Trends & Outlook
  • 13.1 AI-Assisted Real-Time Polyp and Lesion Detection Integrated into Single Use Endoscope Platforms
  • 13.2 Hybrid Reusable-Handle / Disposable-Insertion-Tube Models Redefining the Cost-Per-Procedure Calculus
  • 13.3 Environmental Sustainability Pressure Driving Development of Recyclable and Bio-Based Single Use Endoscope Materials
  • 13.4 Long-Term Market Outlook (2033-2035)
  • 13.5 Investment & M&A Activity Outlook

Frequently asked questions

What is the size of the single use endoscopy device market?
The global single use endoscopy device market was valued at approximately USD 2.1 billion in 2024 and is projected to reach USD 5.8 billion by 2032. In volume terms, the market is estimated at approximately 38 million units in 2024, expected to exceed 95 million units by 2032, reflecting strong procedural volume growth across pulmonology, gastroenterology, and urology applications.
What is the CAGR of the single use endoscopy device market?
The global single use endoscopy device market is forecast to grow at a compound annual growth rate of approximately 13.6% over the 2025–2032 forecast period, making it one of the fastest-growing sub-segments within the broader medical devices landscape.
What is driving growth in the single use endoscopy device market?
Three specific drivers are powering market expansion. First, FDA guidance mandating enhanced reprocessing protocols for duodenoscopes — and the agency's endorsement of single use alternatives following high-profile HAI outbreaks — has triggered institutional adoption across U.S. academic and community hospitals. Second, the rapid build-out of ambulatory surgical centers, particularly across North America and Asia Pacific, has created a large installed base of facilities without reprocessing infrastructure, making disposables operationally and economically compelling. Third, advances in chip-on-tip imaging and single use polymer engineering have substantially closed the image quality gap with premium reusable endoscopes, removing a historically decisive clinical barrier to adoption.
Who are the leading companies in the single use endoscopy device market?
The market is led by Ambu A/S, the Danish pioneer that effectively created the commercial single use bronchoscope category with its aScope platform. Boston Scientific holds a strong position following its LithoVue single use ureteroscope franchise. Olympus Corporation, historically dominant in reusable endoscopy, has entered the single use segment to defend market share. Karl Storz and Medtronic also maintain significant commercial presences, while Chinese manufacturers including Pusen Medical, OTU Medical, and Vathin Medical Technology are gaining share through competitive pricing across Asia Pacific and emerging markets.
Which region dominates the single use endoscopy device market?
North America is the dominant regional market, accounting for approximately 42% of global revenue in 2024, underpinned by the FDA's infection-control regulatory actions, a large and well-funded ambulatory surgical center sector, and high procedural volumes in bronchoscopy and ureteroscopy. However, Asia Pacific is the fastest-growing region, driven by healthcare infrastructure investment in China and India and accelerating adoption of disposable endoscopy across outpatient settings.
What segments are covered in this report?
The report covers segmentation by device type — including single use bronchoscopes, duodenoscopes, ureteroscopes, colonoscopes and sigmoidoscopes, cystoscopes and urological endoscopes, and nasopharyngoscopes and ENT endoscopes — and by application, encompassing pulmonology and critical care bronchoscopy, gastrointestinal endoscopy and ERCP, urology stone management and upper tract surveillance, colorectal screening, and ENT diagnostics. Regional segmentation spans North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, with country-level detail for the United States, Germany, United Kingdom, China, Japan, and India.
What is the forecast period covered in this report?
The report covers the forecast period from 2025 to 2032, with 2024 serving as the base year. Historical market data is provided for the period 2019 to 2024 to establish trend context and pre- and post-pandemic demand patterns.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.